Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Astex Pharmaceuticals, Inc.

http://www.astx.com

Latest From Astex Pharmaceuticals, Inc.

Rhythm Wins Reimbursement For Obesity Drug Imcivree In France & England

France is set to become the first country in Europe to fund Imcivree for a second – and as yet unapproved – indication. Meanwhile, England has agreed to reimburse the drug for its approved indication as did Germany earlier this year. Reimbursement discussions are underway in the rest of Europe.

Reimbursement Metabolic Disorders

ALS Drugs: A Long History Of Regulatory Twists At US FDA

The US FDA is set for two high-profile advisory committee meetings on potential ALS treatments before the end of 2022. Whatever the outcome, they will fit a pattern: when it comes to ALS treatments, there is very little about the regulatory process that feels routine.

BioPharmaceutical United States

Kite Wins EMA Recommendation To Market Tecartus For Leukemia Patients

The European Medicines Agency has recommended new uses for six approved products, including the CAR T-cell therapy Tecartus. 

Cancer Approvals

Rhythm Eyes Bigger Market For Imcivree Following Phase II Hypothalamic Obesity Promise

The US firm’s Imcivree has impressed with interim mid-stage data from a hypothalamic obesity study, paving the way for pivotal success that could open up a much larger market.

Clinical Trials Metabolic Disorders
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Montigen Pharmaceuticals
    • SuperGen, Inc.
UsernamePublicRestriction

Register